Truist Financial’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
Other funds holding ASND
Truist Financial's ASND Position: Q3 2026 in Review
Truist Financial increased its Ascendis Pharma (ASND) stake by 6.6% in Q3 2026, buying an estimated $26.6K and bringing the position to 1,696 shares worth $386K. The position accounts for ﹤0.01% of the portfolio, ranked #2358.
Truist Financial first reported a position in ASND in Q2 2020 and has held it in 6 quarters since. The position peaked at $424K in Q2 2026. 347 funds tracked by Wall St. Rank hold ASND as of Q3 2026.
- Truist Financial held 1,696 shares of Ascendis Pharma worth $386K as of Q3 2026.
- Truist Financial bought 105 Ascendis Pharma shares in Q3 2026, an estimated $26.6K.
- Ascendis Pharma made up ﹤0.01% of Truist Financial's portfolio in Q3 2026, its #2358 holding.
- Truist Financial first reported a position in Ascendis Pharma in Q2 2020 and has held it in 6 quarters since.
- Truist Financial's Ascendis Pharma position peaked at $424K in Q2 2026.
- 347 funds tracked by Wall St. Rank held Ascendis Pharma as of Q3 2026.
Based on Truist Financial's 13F filing for Q3 2026, filed 30 Oct 2026.